Tiamulin

Tiamulin is a semi-synthetic pleuromutilin antibiotic that selectively inhibits bacterial protein synthesis at the 50S ribosomal subunit, retaining importance in veterinary medicine for treating swine and poultry respiratory and enteric infections. Its distinct mechanism helps address resistance concerns where classical antibiotic classes fall short. Simson Pharma offers a Tiamulin reference standard suited to veterinary pharmaceutical QC programmes.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Tiamulin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Tiamulin Fumarate
Tiamulin Fumarate
Tiamulin Fumarate EP Impurity L
Tiamulin EP impurity H
Tiamulin EP impurity L
Tiamulin EP Impurity R
Tiamulin EP impurity I
Tiamulin EP impurity Q
Tiamulin EP impurity S
Tiamulin EP impurity T Fumarate
Tiamulin EP Impurity R Iodide
Tiamulin EP Impurity O Hydrochloride salt
8-Alpha-Hydroxy Mutilin
Tiamulin
Tiamulin EP Impurity G
Tiamulin EP Impurity O
Tiamulin EP Impurity A
Tiamulin EP Impurity B
Tiamulin EP Impurity J
Tiamulin EP Impurity K
Tiamulin EP Impurity M
Tiamulin EP Impurity N
Tiamulin EP Impurity P
Tiamulin EP Impurity E